Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M, Kurokawa T, Ishiyama K, Aoki G, Ueda M, Matano S, Takami A, Yamazaki H, Sawazaki A, Yamauchi H, Yoshida T, Nakao S. Yamaguchi M, et al. Among authors: sawazaki a. Ann Hematol. 2011 Oct;90(10):1209-17. doi: 10.1007/s00277-011-1277-1. Epub 2011 Jun 22. Ann Hematol. 2011. PMID: 21695388 Clinical Trial.
[Primary pleural non-Hodgkin's lymphoma without chronic pyothorax].
Kanno M, Nakamura S, Uotani C, Terasaki Y, Ikeno T, Okumura H, Matano S, Hattori N, Kyoda K, Sawazaki A, Kondo Y, Minato H. Kanno M, et al. Among authors: sawazaki a. Rinsho Ketsueki. 1999 Aug;40(8):678-84. Rinsho Ketsueki. 1999. PMID: 10496045 Japanese.
Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04).
Murayama T, Fukuda T, Okumura H, Sunami K, Sawazaki A, Maeda Y, Tsurumi H, Uike N, Hidaka T, Takatsuka Y, Eto T, Tsuda H, Fujisaki T, Miyamoto T, Tsuneyoshi N, Iyama S, Nagafuji K, Harada M. Murayama T, et al. Among authors: sawazaki a. Int J Hematol. 2016 Jun;103(6):676-85. doi: 10.1007/s12185-016-1976-4. Epub 2016 Mar 21. Int J Hematol. 2016. PMID: 27084252 Clinical Trial.
Five-year follow-up of a phase II study of DA-EPOCH-R with high-dose MTX in CD5-positive DLBCL.
Miyazaki K, Sakai R, Iwaki N, Yamamoto G, Murayama K, Nishikori M, Sunami K, Yoshida I, Yano H, Takahashi N, Okamoto A, Munemoto S, Sawazaki A, Suehiro Y, Fukuhara N, Wake A, Arai A, Masaki Y, Toyama K, Yokoyama A, Tsunemine H, Hasegawa Y, Matsumoto K, Yamada T, Nishimura Y, Tamaru S, Asano N, Miyawaki K, Izutsu K, Kinoshita T, Suzuki R, Ohshima K, Kato K, Katayama N, Yamaguchi M. Miyazaki K, et al. Among authors: sawazaki a. Cancer Sci. 2023 Jun;114(6):2689-2691. doi: 10.1111/cas.15784. Epub 2023 Mar 16. Cancer Sci. 2023. PMID: 36929591 Free PMC article. Clinical Trial. No abstract available.
A case of prolonged COVID-19 treated with tixagevimab/cilgavimab.
Shimizu T, Shirasaki H, Okafuji K, Sawazaki A, Iwabuchi T, Matubayashi R. Shimizu T, et al. Among authors: sawazaki a. Respirol Case Rep. 2023 Feb 9;11(3):e01099. doi: 10.1002/rcr2.1099. eCollection 2023 Mar. Respirol Case Rep. 2023. PMID: 36789174 Free PMC article.
14 results